COMPOSITION FOR THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA COMPRISIN DEGARELIX

Patent No. 597060 Disclosed is a pharmaceutical composition for the treatment of benign prostate hyperplasia; the pharmaceutical composition comprising 9 mg to 40 mg degarelix or pharmaceutically acceptable salt thereof; and a solvent; wherein the concentration of degarelix or salt thereof in the so...

Full description

Saved in:
Bibliographic Details
Main Authors PETRI, AXEL, NICLAS, ERICHSEN LARS
Format Patent
LanguageEnglish
Published 31.05.2013
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Patent No. 597060 Disclosed is a pharmaceutical composition for the treatment of benign prostate hyperplasia; the pharmaceutical composition comprising 9 mg to 40 mg degarelix or pharmaceutically acceptable salt thereof; and a solvent; wherein the concentration of degarelix or salt thereof in the solvent is from 35 to 45 mg/mL. Also disclosed are a kit and a method of preparing said composition.
Bibliography:Application Number: NZ20100597060